Amino- and chloro-8-hydroxyquinolines and their copper complexes as proteasome inhibitors and antiproliferative agents(462 views) Oliveri V, Lanza V, Milardi D, Viale M, Maric I, Sgarlata C, Vecchio G
Metallomics (ISSN: 1756-5901, 1756-591x), 2017 Oct 18; 9(10): 1439-1446.
Dipartimento di Scienze Chimiche, Universita degli Studi di Catania, Viale A. Doria 6, 95125 Catania, Italy. gr.vecchio@unict.it.,
Consorzio Interuniversitario di Ricerca in Chimica Dei Metalli Nei Sistemi Biologici, C.I.R.C.M.S.B., Unità di Ricerca di Catania, Viale A. Doria 6, Catania, 95125, Italy
Istituto di Biostrutture e Bioimmagini, CNR, Via P. Gaifami 18, Catania, 95126, Italy
Ospedale Policlinico San Martino, U.O.C. Bioterapie, Lgo R. Benzi 10, Genova, 16132, Italy
References: Brooks, P., Fuertes, G., Murray, R.Z., Bose, S., Knecht, E., Rechsteiner, M.C., Hendil, K.B., Rivett, J., Subcellular localization of proteasomes and their regulatory complexes in mammalian cells (2000) Biochem. J., 346, pp. 155-16
Arendt, C.S., Hochstrasser, M., Identification of the yeast 20S proteasome catalytic centers and subunit interactions required for active-site formation (1997) Proc. Natl. Acad. Sci. U. S. A., 94, pp. 7156-7161
Heinemeyer, W., Fischer, M., Krimmer, T., Stachon, U., Wolf, D.H., The active sites of the eukaryotic 20 S proteasome and their involvement in subunit precursor processing (1997) J. Biol. Chem., 272, pp. 25200-25209
Kisselev, A.F., Callard, A., Goldberg, A.L., Importance of the different proteolytic sites of the proteasome and the efficacy of inhibitors varies with the protein substrate (2006) J. Biol. Chem., 281, pp. 8582-8590
Kisselev, A.F., Goldberg, A.L., Proteasome inhibitors: From research tools to drug candidates (2001) Chem. Biol., 8, pp. 739-758
Santoro, A.M., Cunsolo, A., D'Urso, A., Sbardella, D., Tundo, G.R., Ciaccio, C., Coletta, M., Purrello, R., Cationic porphyrins are tunable gatekeepers of the 20S proteasome (2016) Chem. Sci., 7, pp. 1286-1297
Santoro, A.M., Lo Giudice, M.C., D'Urso, A., Lauceri, R., Purrello, R., Milardi, D., Cationic Porphyrins Are Reversible Proteasome Inhibitors (2012) J. Am. Chem. Soc., 134, pp. 10451-10457
Almond, J.B., Cohen, G.M., The proteasome: A novel target for cancer chemotherapy (2002) Leukemia, 16, pp. 433-443
Gandin, V., Pellei, M., Tisato, F., Porchia, M., Santini, C., Marzano, C., A novel copper complex induces paraptosis in colon cancer cells via the activation of ER stress signaling (2012) J. Cell. Mol. Med., 16, pp. 142-151
Gandin, V., Tisato, F., Dolmella, A., Pellei, M., Santini, C., Giorgetti, M., Marzano, C., Porchia, M., In Vitro and in Vivo Anticancer Activity of Copper(i) Complexes with Homoscorpionate Tridentate Tris (pyrazolyl) borate and Auxiliary Monodentate Phosphine Ligands (2014) J. Med. Chem., 57, pp. 4745-4760
Kisselev, A.F., Van Der Linden, W.A., Overkleeft, H.S., Proteasome inhibitors: An expanding army attacking a unique target (2012) Chem. Biol., 19, pp. 99-115
Chen, D., Frezza, M., Schmitt, S., Kanwar, J., Dou, Q.P., Bortezomib as the first proteasome inhibitor anticancer drug: Current status and future perspectives (2011) Curr. Cancer Drug Targets, 11, pp. 239-253
Orlowski, R.Z., Kuhn, D.J., Proteasome inhibitors in cancer therapy: Lessons from the first decade (2008) Clin. Cancer Res., 14, pp. 1649-1657
Oliveri, V., Giuffrida, M.L., Vecchio, G., Aiello, C., Viale, M., Gluconjugates of 8-hydroxyquinolines as potential anti-cancer prodrugs (2012) Dalton Trans., 41, pp. 4530-4535
Oliveri, V., Vecchio, G., 8-Hydroxyquinolines in medicinal chemistry: A structural perspective (2016) Eur. J. Med. Chem., 120, pp. 252-274
Ruschak, A.M., Slassi, M., Kay, L.E., Schimmer, A.D., Novel proteasome inhibitors to overcome bortezomib resistance (2011) J. Natl. Cancer Inst., 103, pp. 1007-1017
Santoro, A.M., Monaco, I., Attanasio, F., Lanza, V., Pappalardo, G., Tomasello, M.F., Cunsolo, A., Milardi, D., Copper(II) ions affect the gating dynamics of the 20S proteasome: A molecular and in cell study (2016) Sci. Rep., 6, p. 33444
Daniel, K.G., Gupta, P., Harbach, R.H., Guida, W.C., Dou, Q.P., Organic copper complexes as a new class of proteasome inhibitors and apoptosis inducers in human cancer cells (2004) Biochem. Pharmacol., 67, pp. 1139-1151
Wang, T., Guo, Z.J., Copper in medicine: Homeostasis, chelation therapy and antitumor drug design (2006) Curr. Med. Chem., 13, pp. 525-537
Adsule, S., Barve, V., Chen, D., Ahmed, F., Dou, Q.P., Padhye, S., Sarkar, F.H., Novel Schiff base copper complexes of quinoline-2 carboxaldehyde as proteasome inhibitors in human prostate cancer cells (2006) J. Med. Chem., 49, pp. 7242-7246
Heidary, D.K., Howerton, B.S., Glazer, E.C., Coordination of Hydroxyquinolines to a Ruthenium Bis-dimethylphenanthroline, Scaffold Radically Improves Potency for Potential as Antineoplastic Agents (2014) J. Med. Chem., 57, pp. 8936-8946
Milardi, D., Arnesano, F., Grasso, G., Magrì, A., Tabbì, G., Scintilla, S., Natile, G., Rizzarelli, E., Ubiquitin Stability and the Lys 63-Linked Polyubiquitination Site Are Compromised on Copper Binding (2007) Angew. Chem., Int. Ed., 46, pp. 7993-7995
Arena, G., Bellia, F., Frasca, G., Grasso, G., Lanza, V., Rizzarelli, E., Tabbì, G., Milardi, D., Inorganic stressors of ubiquitin (2013) Inorg. Chem., 52, pp. 9567-9573
Kaiser, S.M., Escher, B.I., The evaluation of liposome-water partitioning of 8-hydroxyquinolines and their copper complexes (2006) Environ. Sci. Technol., 40, pp. 1784-1791
Budimir, A., Humbert, N., Elhabiri, M., Osinska, I., Biruš, M., Albrecht-Gary, A.M., Hydroxyquinoline based binders: Promising ligands for chelatotherapy? (2011) J. Inorg. Biochem., 105, pp. 490-496
Oliveri, V., Grasso, G.I., Bellia, F., Attanasio, F., Viale, M., Vecchio, G., Soluble sugar-based quinoline derivatives as new antioxidant modulators of metal-induced amyloid aggregation (2015) Inorg. Chem., 54, pp. 2591-2602
Oliveri, V., Bellia, F., Pietropaolo, A., Vecchio, G., Unusual Cyclodextrin Derivatives as a New Avenue to Modulate Self- and Metal-Induced Aβ Aggregation (2015) Chem.-Eur. J., 21, pp. 14047-14059
Nancollas, G.H., Tomson, M.B., Guidelines for the determination of stability constants (1982) Pure Appl. Chem., 54, pp. 2675-2692
Sgarlata, C., Oliveri, V., Spencer, J., A 8-Hydroxyquinoline-Cyclodextrin Conjugate as an Efficient Chelating Agent for Cobalt(II) and Nickel(II) in Neutral Aqueous Solution (2015) Eur. J. Inorg. Chem., pp. 5886-5891
Oliveri, V., Sgarlata, C., Vecchio, G., Cyclodextrins 3-Functionalized with 8-Hydroxyquinolines: Copper-Binding Ability and Inhibition of Synuclein Aggregation (2016) Chem.-Asian J., 11, pp. 2436-2442
Oliveri, V., Pietropaolo, A., Sgarlata, C., Vecchio, G., Zinc Complexes of Cyclodextrin-bearing 8-Hydroxyquinoline Ligands: A Comparative Study (2017) Chem.-Asian J., 12, pp. 110-115
Johnston, W.D., Freiser, H., Structure and Behavior of Organic Analytical Reagents. III. Stability of Chelates of 8-Hydroxyquinoline and Analogous Reagents1 (1952) J. Am. Chem. Soc., 74, pp. 5239-5242
Di Vaira, M., Bazzicalupi, C., Orioli, P., Messori, L., Bruni, B., Zatta, P., Clioquinol, a drug for Alzheimer's disease specifically interfering with brain metal metabolism: Structural characterization of its zinc(II) and copper(II) complexes (2004) Inorg. Chem., 43, pp. 3795-3797
Alfano, C., Faggiano, S., Pastore, A., The Ball and Chain of Polyubiquitin Structures (2016) Trends Biochem. Sci., 41, pp. 371-385
Katano, H., Tanaka, R., Maruyama, C., Hamano, Y., Assay of enzymes forming AMP + PPi by the pyrophosphate determination based on the formation of 18-molybdopyrophosphate (2012) Anal. Biochem., 421, pp. 308-312
Berndsen, C.E., Wolberger, C., A spectrophotometric assay for conjugation of ubiquitin and ubiquitin-like proteins (2011) Anal. Biochem., 418, pp. 102-110
Oliveri, V., Viale, M., Caron, G., Aiello, C., Gangemi, R., Vecchio, G., Glycosylated copper(II) ionophores as prodrugs for β-glucosidase activation in targeted cancer therapy (2013) Dalton Trans., 42, pp. 2023-2034
Oliveri, V., New glycoconjugates for the treatment of diseases related to metal dyshomeostasis (2015) ChemistryOpen, 4, pp. 792-795
Fuster, J.J., Sanz-González, S.M., Moll, U.M., Andrés, V., Classic and novel roles ofp53: Prospects for anticancer therapy (2007) Trends Mol. Med., 13, pp. 192-199
Gadducci, A., Cosio, S., Muraca, S., Genazzani, A.R., Molecular mechanisms of apoptosis and chemosensitivity to platinum and paclitaxel in ovarian cancer: Biological data and clinical implications (2002) Eur. J. Gynaecol. Oncol., 23, pp. 390-396
Clark, D.E., Pickett, S.D., Computational methods for the prediction of 'druglikeness' (2000) Drug Discovery Today, 5, pp. 49-58
Lipinski, C.A., Lombardo, F., Dominy, B.W., Feeney, P.J., Experimental and computational approaches to estimate solubility and permeability in drug discovery and developments settings (1997) Adv. Drug Delivery Rev., 23, p. 3e25
Gans, P., Sabatini, A., Vacca, A., Investigation of equilibria in solution. Determination of equilibrium constants with the HYPERQUAD suite of programs (1996) Talanta, 43, pp. 1739-1753
Smith, R.M., Martell, A.E., (1976) Critical Stability Constants, , Plenum Press, New York, 4
Crumbliss, A.L., Poulos, A.T., Kinetics of Oxidation of a Cuprous 2,2′,2′′-Terpyridine Complex by Molecular Oxygen (1975) Inorg. Chem., 14, pp. 1529-1534
Dell'Erba, C., Chiavarina, B., Fenoglio, C., Petrillo, G., Cordazzo, C., Boncompagni, E., Spinelli, D., Viale, M., Inhibition of cell proliferation, cytotoxicity and induction of apoptosis of 1,4-bis(1-naphthyl)-2,3-dinitro-1,3-butadiene in gastrointestinal tumour cell lines and preliminary evaluation of its toxicity in vivo (2005) Pharmacol. Res., 52, pp. 271-282
Amino- and chloro-8-hydroxyquinolines and their copper complexes as proteasome inhibitors and antiproliferative agents
Petraglia F, Singh AA, Carafa V, Nebbioso A, Conte M, Scisciola L, Valente S, Baldi A, Mandoli A, Petrizzi VB, Ingenito C, De Falco S, Cicatiello V, Apicella I, Janssen-megens EM, Kim B, Yi G, Logie C, Heath S, Ruvo M, Wierenga ATJ, Flicek P, Yaspo ML, Della Valle V, Bernard O, Tomassi S, Novellino E, Feoli A, Sbardella G, Gut I, Vellenga E, Stunnenberg HG, Mai A, Martens JHA, Altucci L * Combined HAT/EZH2 modulation leads to cancer-selective cell death(284 views) Oncotarget (ISSN: 1949-2553electronic, 1949-2553linking), 2018 May 22; 9(39): 25630-25646. Impact Factor:5.008 ViewExport to BibTeXExport to EndNote
Ntziachristos V, Cuénod CA, Fournier L, Balvay D, Pradel C, Siauve N, Clement O, Jouannot E, Lucidarme O, Vecchio SD, Salvatore M, Law B, Tung C-H, Jain RK, Fukumura D, Munn LL, Brown EB, Schellenberger E, Montet X, Weissleder R, Clerck ND, Postnov A * Tumor Imaging(350 views) Textbook Of In Vivo Imaging In Vertebrates (ISSN: 9780-4700), 2007 Jul 16; 1: 277-309. Impact Factor:1.148 ViewExport to BibTeXExport to EndNote